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Hospitalization rates for intussusception in children aged 0–59 months from 2009 to
2014 in Italy
Vincenzo Restivo, Claudio Costantino, Fabio Tramuto, and Francesco Vitale
Department of Science for Health Promotion and Mother-Child Care “G. D’Alessandro,” University of Palermo, Palermo, Italy
ABSTRACT
The real cause of intussusception is not fully understood and a variety of conditions have been associated with it
(Meckel diverticulum, polyps, duplication cysts, parasites, Henoch-Sch€onlein purpura, cystic ﬁbrosis, hemolytic-
uremic syndrome and infectious gastroenteritis). Furthermore few European countries, following WHO
recommendation to monitor baseline incidence of intussusception before implementation of immunization
program for rotavirus, used intussusception rate as a baseline value to compare the same ﬁgures in the period
before and after introduction of vaccination. In this study, data of intussusception hospitalizations occurred
among Italian children aged 0 through 59months from 2009 to 2014were analyzed.
A total amount of 3,088 children were included, accounting for a hospitalization rate of 20.2 per 100,000.
Overall, the hospitalization rate for intussusception had a slight increase in trend from 2009 to 2014 (18%).
In particular children 0–11 months had a hospitalization rate higher than 12–59 months with an aggregate
value of 36 Vs. 16 per 100,000 respectively. Among all children hospitalized for intussusception a total of
239 (7.7%) had also a previous or concomitant hospitalization for gastroenteritis.
This study demonstrates that Italian hospitalizations for intussusception are increasing by time and the
role played by different risk factors, including acute gastroenteritis, have to be investigated in the future.
These data could be useful to monitor intussusception hospitalization in the perspective of anti-rotavirus
vaccination introduction in Italy.
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Introduction
Intussusception is the invagination of an intestine segment within a
more distal one and it is the most common cause of bowel obstruc-
tion in children.1 About 60% of affected children are under one
year of age and 80% to 90% have less than 2 years, appearing to be
less common before the 3 months and after 6 y.2 In Switzerland,
from 2003 to 2006, the mean yearly incidence rates of intussuscep-
tion in the ﬁrst, second, and third year of life were 38, 31, and 26
cases per 100,000, respectively.3 Furthermore, German estimated
crude incidence for children younger than 1 y was 26.6/100,000,
with only minor seasonal ﬂuctuations.4
Themost accredited pathogenesis ascribes intussusception to an
imbalance of longitudinal forces caused by a mass connecting with
disorganized pattern of peristalsis.5 However, the etiology of intus-
susceptions is likely attributable to a combination of several condi-
tions, including Meckel diverticulum,6 polyps,7 duplication cysts,8
parasites (eg, Ascaris lumbricoides),9 Henoch-Sch€onlein purpura,10
cystic ﬁbrosis,11 and hemolytic-uremic syndrome.12 Furthermore,
an increasing body of evidence has suggested also viral triggers as
contributors, identifying a strong association with enteric and non-
enteric species of adenovirus, for which the evidence of recent
infection was described from 30 to 40% of cases in different stud-
ies.13,14,15,16 Bacterial enteritis was also associated with intussuscep-
tion. In a series of 293 intussusception cases among children seen
at military treatment facilities, bacterial enteritis ensued in 37 cases
(2.6%). This association was noted for infection with Salmonella,
E. coli, Shigella, or Campylobacter.17
Although some of clinical manifestation are still unknown,
intussusception increased its popularity in the last 2 decades
because of its potential temporal association with rotavirus vac-
cination.18 Anti-RV is a live-attenuated vaccine which have
been designed to mimic the immunologic responses stimulated
by natural rotavirus infection.19 Nowadays in Italy the anti-RV
vaccination is not offered as UMV by the National Health Sys-
tem. In particular, it is supplied by co-payment in some admin-
istrative regions and it is free only for children at risk in others
with small vaccination coverage.20 Among all administrative
Italian regions, Sicily was the ﬁrst to provide the anti-RV vac-
cine as UMV from 2013.21 According to WHO recommenda-
tion, that suggest to monitor baseline incidence of
intussusception before the perspective of rotavirus vaccines
introduction,22 the present study was aimed to evaluate inci-
dence rates of intussusception among infants hospitalized in
Italy from 2009 to 2014, a period without rotavirus vaccination
availability, to deﬁne baseline incidence of intussusception.
Results
A total of 3,437 children, aged 0–59 months, were hospitalized
for intussusception in Italy from 2009 to 2014. Of these 349
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had at least one repeated hospital admission and were excluded
by following analysis. Therefore 3,088 children accounting for
an average 515 cases per year and a hospitalization rate of 20.2
per 100,000 were evaluated in this report. They were more fre-
quently male cases (M:F sex ratio 1.8) with a median age of 1 y
(IQR 0–2). Over one third (n D 1,086; 35.2%) of cases occurred
in the age class 0–11 months. Furthermore 94.2% of hospital-
izations were fully recovered and discharged from hospital, and
only 2 died have occurred for respiratory failure and sepsis
respectively (Table 1). Of all children hospitalized for intussus-
ception a total of 239 (7.7%) had also a concurrent or during
previous 30 d hospitalization for gastroenteritis (data not
shown in table). Among these the more common type of gas-
troenteritis was infectious unspeciﬁed (43.5%) followed by viral
(32.6%), not infectious (13.0%) and bacterial etiology (10.9%).
Figure 1 shows the trends of hospitalization rate for intus-
susception in Italy among children aged 0–59 and in 2 sub-
groups 0–11 and 12–59 months. Among the whole population,
the hospitalization rate showed an increasing trend from 2009
to 2014 (18%) reaching a peak in 2012 of 22.6 per 100,000.
However, children 0–11 months had a hospitalization rate
higher with an aggregate value of 36 per 100,000 and a slight
reduction (¡9%) from 2009 to 2014, whereas, those 12–
59 months were hospitalized with a mean rate of 16 per
100,000 during the study period but showing an increasing
trend with a growth of 40%.
Furthermore, the distribution of intussusception hospitaliza-
tions by month of age during the ﬁrst year of life shows a higher
rate of hospital admissions in the second half of the year than in
the ﬁrst half. In particular there is an increase number of intus-
susceptions from 4 months of age reaching a peak during
7 months of age with a value of 138 cases (Fig. 2).
Discussion
This study reported the baseline hospitalization rate for intus-
susception in Italy, a country without nationwide rotavirus vac-
cination availability. Italian hospitalization rate for
intussusception in children 0–59 months increased in hospitali-
zation rate of 18% during the study period. A similar raising
trend was also showed in France, where it was analyzed emer-
gency department data in children below 18 y.23 Furthermore,
Italian data according to other studies, demonstrate a major
risk of intussusception hospitalization among children
0–11 months than 12–59 months.2,24 In detail, hospitalization
rate of 0–11 months children with a value of 36.5 per 100,000
was similar to value reported in Switzerland (38 per 100,000),3
but slightly increased than hospitalization rate reported in Ger-
many and the UK (26.2 and 24.8 per 100,000 respectively).4,25
Overall, these data conﬁrm that intussusception is a relatively
frequent disease during the ﬁrst year of life probably due to a
higher exposure to risk factors and the higher frequency of
atypical clinical manifestation leading to a delay in healthcare
treatment.26,27 Even if these different data among neighboring
nations could reﬂect different organization levels of primary
care that should be evaluated in future comparison.
Moreover, the increasing number of intussusception cases in
Italy needs to investigate risk factors associated with its origin.
Although our study was based on ofﬁcial HDR, and we were
unable to evaluate potential risk factors acting before intussus-
ception onset, some considerations have to be done. Several
studies identiﬁed the possible risk factors in breastfeeding,
health status of children, environmental characteristics and gas-
troenteritis of different etiology.17,28,29 This latter relationship
was supported by the disproportionate development of the
immune response and a consequent lymphoid tissue hypertro-
phy of the Peyer’s patches in children with gastroenteritis that
Table 1. Characteristics of children hospitalized for intussusception aged
0–59 months in Italy (2009–2014).
Italian intussusception hospitalization N D 3,088
Gender, n (%)
Male 1,970 (63.8)
Female 1,118 (36.2)
Age, median in year (IQ range) 1 (0–2)
Age classes in months, n (%)
0–11 1,086 (35.2)
12–59 2,002 (64.8)
Hospitalization rate per 100,000 (CI 95%)
0–11 months 36.5 (32.9–40.1)
12–59 months 16.2 (13.4–19.2)
0–59 months 20.2 (18.0–22.4)
Mean of intussusception hospitalizations per year ( § SD) 515 (45.5)
Hospitalization length, median in days (IQ range) 3 (2–5)
Discharge status, n (%)
Transferred 178 (5.7)
Death 2 (0.1)
Discharged 2,908 (94.2)
Figure 1. Intussusception hospitalization rate by age in months among Italian chil-
dren (2009–2014).
Figure 2. Intussusception hospitalization cases during ﬁrst year of life (2009–2014).
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exposed them at greater risk of intussusception.30 In Italian
children a little percentage of cases (7.7%) occurred in those
who had a concurrent or 30-day previous hospital admission
for severe gastroenteritis. In detail, the percentage of Italian
intussusception with gastroenteritis was less than Germany and
Switzerland (18% and 24% of children hospitalized for intus-
susception respectively).4,3 Italian HDR data also revealed
undetermined infectious type as the most frequent cause of gas-
troenteritis hospital admission in children with intussusception.
This phenomenon can be partially explained with lack to per-
form test identifying etiology of gastroenteritis in clinical
practice.31
Furthermore, these data provide evidence on the age onset
of intussusception in children 0–11 months before anti-RV vac-
cination introduction. In detail, intussusception among Italian
children 0–11 months without vaccination had an initial
increase during 4th month with a peak in the 7th month of life.
This increase was in accordance to data reported among chil-
dren hospitalized in Switzerland and the UK.3,25
In our series mortality for intussusception occurred in <1%
of patients. This result was in accordance with those reported
in developed countries,32 whereas in countries where access to
quality health care is less common it was reported a median
intussusception mortality of 11%.33 The 2 Italian deaths seem
can be due to a delayed access to health services which is well
recognized to be associated with adverse outcomes and poor
prognosis.34 This ﬁnding underscores the importance of
increasing awareness about intussusception and understanding
the atypical clinical presentation among healthcare provider.35
A main limit of this study must be stressed, because the use
of HDR could be cause of underestimation according to inter-
national reported data about intussusception cases missed in
analyses using only inpatient discharge data.36 However, in our
opinion, considering the temporal stability of hospitalized
intussusception cases and the long period analyzed in this Ital-
ian study, HDR-based inpatient data could be a reasonable
proxy for overall intussusception rates and should reﬂect its
trends over time.
Finally this study demonstrated an intussusceptions increas-
ing trend during study period in absence of a nationwide anti-
RV vaccination program. This data should be considered useful
to investigate the speciﬁc role played by different risk factors in
order to sustain the introduction of anti-rotavirus vaccination
in Italy.
Material and methods
This analysis included data of hospitalizations occurred among
children aged 0 through 59 months from 2009 to 2014 and resi-
dent in Italy, a country with a newborn cohort of about 500,000
children per year.
HDR were the source of data and they were obtained from
the Italian Ministry of Health Ofﬁce, which routinely collects
these data from all national public and private hospitals. Each
HDR includes admission and discharge dates, discharge status
(categorized as “discharged,” “transferred” or “death”), demo-
graphic information (birthplace, residence, gender, and age)
and up to 6 discharge diagnoses (1 principal and 5 secondary
diagnoses) coded according to ICD-9-CM.
Cases of intussusception were deﬁned as all hospitalizations
with an ICD-9-CM diagnosis code of 560.0 included among
one of discharge diagnoses. Moreover, hospitalization for bac-
terial gastroenteritis (ICD-9-CM diagnosis code from 001 to
005 excluding 005.2 and including from 008.0 to 008.5), para-
sitic gastroenteritis (ICD-9-CM diagnosis code from 006 to 007
excluding 006.2–006.6), viral gastroenteritis (ICD-9-CM diag-
nosis code from 008.6 to 008.8), gastroenteritis of unspeciﬁed
infectious origin (ICD-9-CM diagnosis code from 009.0 to
009.3) and not infectious gastroenteritis (ICD-9-CM diagnosis
code from 558 to 558.9) were also comparatively analyzed in
the same children with intussusception.37 Repeated cases of
intussusception were excluded from the analysis due to an
anonymous code of identiﬁcation.
Furthermore, hospitalizations for intussusception occurred
among Sicilian children were excluded from this study because
there was already implemented a UMV against rotavirus from
2013 and intussusception hospitalization was already
analyzed.24,38,39,40
Statistical analysis
Hospitalization rates (per 100,000) and CI 95% for each investi-
gated year were calculated using the census population for chil-
dren aged 5 or less years. The trends in infants’ hospitalizations
were analyzed after stratifying by sex and age. To compare nor-
mally and not normally distributed variables were used Stu-
dent’s t-test and Mann–Whitney test respectively. Chi-square
were used to compare categorical variables. Statistical signiﬁ-
cance was set at p < 0.05 (p values are 2-tailed). All analyses
were performed using the STATA v14.1 software package.
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